deal-risk-assessment

Assess sales deal health by scoring opportunities across six weighted dimensions like Champion Strength and Technical Fit, automatically identifying red flags to improve forecast accuracy. This structured methodology replaces gut-feel evaluations with systematic pipeline risk management.

Deal scoring for clinical trial EDC sales works by evaluating opportunities across six key dimensions and identifying EDC-specific red flags like CRO Mandate or Regulatory Filing Dependency. It flags critical issues to recommend corrective actions and adjust pipeline forecast value.

Improve sales forecast accuracy by using a structured scoring framework to calculate weighted pipeline value based on deal health. Identifying specific red flags and warning signs early allows you to adjust your forecast methodology and remove critical risks from the pipeline.

Yes, pipeline management scoring can spot a ghost champion or close date slippage by automatically flagging these critical issues during the deal assessment. It also catches warning signs like expanding evaluations and budget uncertainty to prevent forecast surprises.

When evaluating clinical trial EDC deals, look for specific red flags like CRO Mandate and Regulatory Filing Dependency, alongside standard sales risks like Ghost Champion and Close Date Slippage. Spotting these warning signs early enables actionable corrective steps.